Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Panacos Pharmaceuticals, Inc.
No Price
Closing Price OTC 28.04.2026:
0,0001 USD
28.04.2026 20:00
Current Prices from Panacos Pharmaceuticals, Inc.
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
UTC
PANC
USD
28.04.2026 20:00
0,0001 USD
0,00 USD
Company Profile for Panacos Pharmaceuticals, Inc. Share
Panacos Pharmaceuticals, Inc., a development stage biotechnology company, engages in the discovery and development of small-molecule oral drugs designed to treat human immunodeficiency virus (HIV) and other human viral diseases. The company's discovery technologies focus on novel targets in the virus life cycle, including virus maturation and virus fusion. Its product pipeline includes second- and third-generation programs in HIV maturation inhibition. The company was founded in 1999 and is headquartered in Watertown, Massachusetts.
